Bacterial Biofilms in Complex Infection Environments: Challenges and Novel Therapeutic Perspectives

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Biotechnology".

Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 12789

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Chemistry, Biotechnology and Food Science, The Norwegian University of Life Sciences, 1432 Ås, Norway
Interests: antibiotic resistance; biofilm; bacterial infection; bacteriology; MRSA; cell biology

Special Issue Information

Dear Colleagues,

Although a sessile microbial community was first observed in the 17th century, the modern concept of bacterial biofilms and their relevance for human and veterinary medicine was only recognized in the early 1970s. Since then, research interest in biofilm-associated infections has increased dramatically, and today, we know that approximately 80% of chronic and recurrent bacterial infections in humans are associated with biofilms. Bacterial biofilms are inherently complex structures, where integrated cues from quorum-sensing systems and the surrounding environment modulate the patterns of bacterial cell gene expression, metabolism, and interaction with the local host microenvironment and the immune system. The protection offered by biofilms to bacterial communities dramatically contributes to increasing their resilience to antimicrobial treatments, and together with the spread of genetically encoded antibiotic resistance, they represent an extraordinary threat to human and veterinary health. Furthermore, increasing evidence suggests that biofilms can serve as environmental reservoirs of antimicrobial resistance. Altogether, this underscores the compelling importance of improving our understanding of how these microbial communities are regulated and how they interact with the host during infection and, ultimately, develop targeted therapeutic strategies to eradicate them. In this Special Issue, we aim to attract review and perspective papers of outstanding quality and scientific content on the involvement of bacterial biofilms in human and veterinary infections. We invite works on biofilms brought about by Gram-positive as well as Gram-negative bacteria aimed at providing a deeper understanding of their mode of regulation and the pattern of host–pathogen interactions using state-of-the-art research tools and next-generation high-throughput approaches. Moreover, we welcome perspectives on novel biofilm-oriented therapeutic tools and strategies.

Dr. Christian Kranjec
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biofilm
  • antibiotic resistance
  • bacterial infections
  • Gram-negative bacteria
  • Gram-positive bacteria
  • extracellular matrix (ECM)
  • immune evasion
  • omics
  • metabolism
  • quorum-sensing

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

19 pages, 8290 KiB  
Article
Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa, Proteus mirabilis, and Serratia marcescens
by Abrar K. Thabit, Khalid Eljaaly, Ayat Zawawi, Tarek S. Ibrahim, Ahmed G. Eissa, Samar S. Elbaramawi, Wael A. H. Hegazy and Mahmoud A. Elfaky
Biology 2022, 11(9), 1349; https://doi.org/10.3390/biology11091349 - 13 Sep 2022
Cited by 17 | Viewed by 2274
Abstract
Quorum sensing (QS) controls the production of several bacterial virulence factors. There is accumulative evidence to support that targeting QS can ensure a significant diminishing of bacterial virulence. Lessening bacterial virulence has been approved as an efficient strategy to overcome the development of [...] Read more.
Quorum sensing (QS) controls the production of several bacterial virulence factors. There is accumulative evidence to support that targeting QS can ensure a significant diminishing of bacterial virulence. Lessening bacterial virulence has been approved as an efficient strategy to overcome the development of antimicrobial resistance. The current study aimed to assess the anti-QS and anti-virulence activities of α-adrenoreceptor prazosin against three virulent Gram-negative bacteria Pseudomonades aeruginosa, Proteus mirabilis, and Serratia marcescens. The evaluation of anti-QS was carried out on a series of in vitro experiments, while the anti-virulence activities of prazosin were tested in an in vivo animal model. The prazosin anti-QS activity was assessed on the production of QS-controlled Chromobacterium violaceum pigment violacein and the expression of QS-encoding genes in P. aeruginosa. In vitro tests were performed to evaluate the prazosin effects on biofilm formation and production of extracellular enzymes by P. aeruginosa, P. mirabilis, and S. marcescens. A protective assay was conducted to evaluate the in vivo anti-virulence activity of prazosin against P. aeruginosa, P. mirabilis, and S. marcescens. Moreover, precise in silico molecular docking was performed to test the prazosin affinity to different QS receptors. The results revealed that prazosin significantly decreased the production of violacein and the virulent enzymes, protease and hemolysins, in the tested strains. Prazosin significantly diminished biofilm formation in vitro and bacterial virulence in vivo. The prazosin anti-QS activity was proven by its downregulation of QS-encoding genes and its obvious binding affinity to QS receptors. In conclusion, prazosin could be considered an efficient anti-virulence agent to be used as an adjuvant to antibiotics, however, it requires further pharmacological evaluations prior to clinical application. Full article
Show Figures

Figure 1

Review

Jump to: Research

21 pages, 2619 KiB  
Review
Quorum Sensing in ESKAPE Bugs: A Target for Combating Antimicrobial Resistance and Bacterial Virulence
by Sirijan Santajit, Nitat Sookrung and Nitaya Indrawattana
Biology 2022, 11(10), 1466; https://doi.org/10.3390/biology11101466 - 06 Oct 2022
Cited by 10 | Viewed by 6819
Abstract
A clique of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. (ESKAPE) bugs is the utmost causative agent responsible for multidrug resistance in hospital settings. These microorganisms employ a type of cell–cell communication [...] Read more.
A clique of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. (ESKAPE) bugs is the utmost causative agent responsible for multidrug resistance in hospital settings. These microorganisms employ a type of cell–cell communication termed ‘quorum sensing (QS) system’ to mediate population density and synchronously control the genes that modulate drug resistance and pathogenic behaviors. In this article, we focused on the present understanding of the prevailing QS system in ESKAPE pathogens. Basically, the QS component consisted of an autoinducer synthase, a ligand (e.g., acyl homoserine lactones/peptide hormones), and a transcriptional regulator. QS mediated expression of the bacterial capsule, iron acquisition, adherence factors, synthesis of lipopolysaccharide, poly-N-acetylglucosamine (PNAG) biosynthesis, motility, as well as biofilm development allow bacteria to promote an antimicrobial-resistant population that can escape the action of traditional drugs and endorse a divergent virulence production. The increasing prevalence of these harmful threats to infection control, as well as the urgent need for effective antimicrobial strategies to combat them, serve to highlight the important anti-QS strategies developed to address the difficulty of treating microorganisms. Full article
Show Figures

Figure 1

20 pages, 1693 KiB  
Review
Virulence Characteristics and Emerging Therapies for Biofilm-Forming Acinetobacter baumannii: A Review
by Karma G. Dolma, Rachana Khati, Alok K. Paul, Mohammed Rahmatullah, Maria de Lourdes Pereira, Polrat Wilairatana, Bidita Khandelwal, Chamma Gupta, Deepan Gautam, Madhu Gupta, Ramesh K. Goyal, Christophe Wiart and Veeranoot Nissapatorn
Biology 2022, 11(9), 1343; https://doi.org/10.3390/biology11091343 - 12 Sep 2022
Cited by 5 | Viewed by 3063
Abstract
Acinetobacter species is one of the most prevailing nosocomial pathogens with a potent ability to develop antimicrobial resistance. It commonly causes infections where there is a prolonged utilization of medical devices such as CSF shunts, catheters, endotracheal tubes, and similar. There are several [...] Read more.
Acinetobacter species is one of the most prevailing nosocomial pathogens with a potent ability to develop antimicrobial resistance. It commonly causes infections where there is a prolonged utilization of medical devices such as CSF shunts, catheters, endotracheal tubes, and similar. There are several strains of Acinetobacter (A) species (spp), among which the majority are pathogenic to humans, but A. baumannii are entirely resistant to several clinically available antibiotics. The crucial mechanism that renders them a multidrug-resistant strain is their potent ability to synthesize biofilms. Biofilms provide ample opportunity for the microorganisms to withstand the harsh environment and further cause chronic infections. Several studies have enumerated multiple physiological and virulence factors responsible for the production and maintenance of biofilms. To further enhance our understanding of this pathogen, in this review, we discuss its taxonomy, pathogenesis, current treatment options, global resistance rates, mechanisms of its resistance against various groups of antimicrobials, and future therapeutics. Full article
Show Figures

Figure 1

Back to TopTop